Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial

MLA

Richard Perez-Perez, et al. Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. June 2021. EBSCOhost, https://doi.org/10.1101/2021.06.14.21258569.

APA

Richard Perez-Perez, Gary Herman, Jennifer D. Hamilton, Leah Lipsich, Meagan P. O’Brien, Divya Ramesh, George D. Yancopoulos, John D. Davis, Bari Kowal, James Krainson, Ingeborg Heirman, Alina Baum, Neena Sarkar, Adnan Mahmood, Kenneth C. Turner, Christos A. Kyratsous, Rizwana Mohseni, Ruanne V. Barnabas, Dale R. Burwen, … Yunji Kim. (2021). Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. https://doi.org/10.1101/2021.06.14.21258569

Chicago

Richard Perez-Perez, Gary Herman, Jennifer D. Hamilton, Leah Lipsich, Meagan P. O’Brien, Divya Ramesh, George D. Yancopoulos, et al. 2021. “Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial,” June. doi:10.1101/2021.06.14.21258569.